Interpretable Machine Learning for Mitochondrial Toxicity Prediction: Cross-Assay Generalization, Descriptor Transferability, and Context-Dependent Structural Effects
Mitochondrial toxicity is a major concern in drug development and safety assessment. Machine learning models trained on mitochondrial membrane potential (MMP) assay data offer promising toxicity predictions, but cross-scaffold and cross-assay transferability remain uncharacterized. We evaluated classical machine learning and deep learning architectures across six molecular representations and both random and scaffold-based splitting strategies, assessing performance on an internal MMP test set and an independent external set comprising flux and glucose–galactose assay data. Across all model configurations, we observed a consistent cross-assay generalization gap, independent of model type, feature choice, or augmentation strategy. Mordred descriptors provided the most transferable predictive signal, outperforming fingerprint-based representations on the external set. SHAP analysis of the best CatBoost and Random Forest models identified autocorrelation-family descriptors as dominant predictors. C3SP3 contributed through feature interactions while ATS5i showed positive association with toxicity across assays. Motif-level and descriptor-level associations proved to be strongly assay-dependent, supporting a mechanism in which mitochondrial toxicity arises from multivariate physicochemical interactions rather than single structural alerts.
Authors
- Yu‐Heng Lin (ORCID: https://orcid.org/0000-0001-9316-8643)
- Yu-Te Lin (ORCID: https://orcid.org/0000-0002-6019-5319)
- An‐Chi Wei (ORCID: https://orcid.org/0000-0001-7927-1636)
Institutions
- National Taiwan University (TW)
Publication Details
- Journal
- Clinical bioenergetics
- Published
- 2026-06-27
- DOI
- https://doi.org/10.3390/clinbioenerg2030011
- Primary Topic
- Computational Drug Discovery Methods
- Type
- article
- Field-Weighted Citation Impact
- 0.00